Biome Australia Ltd (AU:BIO) has released an update. Biome Australia Ltd has successfully identified and validated its new probiotic strain, Lactobacillus plantarum BMB18, marking a significant ...

Unlock your investing potential with TipRanks Premium - Now At 40% OFF! Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter Biome Australia Ltd has strengthened ...

Revenue: AU$18.4m (up 42% from FY 2024). Net income: AU$214.7k (up from AU$1.67m loss in FY 2024). Profit margin: 1.2% (up from net loss in FY 2024). The move to profitability was driven by higher ...

Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying, like in the case of Biome Australia Limited (ASX:BIO), it sends a favourable ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Biome Australia Ltd ( (AU:BIO)) has ...

Bell Potter analyst Martyn Jacobs maintained a Buy rating on Biome Australia Ltd (BIO – Research Report) today and set a price target of A$0.85. The company’s shares closed today at A$0.52. According ...

Here's why Bell Potter thinks this small-cap stock is a buy. The post The ASX small-cap stock that could double in value in ...

Biome Australia Ltd. engages in the research, development, manufacture, and distribution of evidence-based products linking the gut and human health. It offers live biotherapeutics products and ...